Delivery Order SPE2DR25D2100-SPE2DR26FA0PT
- Not listed
- The Defense Logistics Agency awarded a $21,065.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a prescription pharmaceutical product used primarily for cholesterol management. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by November 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $54,832.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick, a pharmaceutical product used in cholesterol management. This firm fixed-price, non-set-aside delivery order was executed on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $15,338.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular treatment. This firm fixed-price, non-set-aside delivery order was issued on November 26, 2025, with an ultimate completion date of November 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,662.32 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a prescription medication used to treat high cholesterol. This competitively awarded, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,089.93 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $45,293.97 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick, a pharmaceutical product used in cardiovascular disease treatment. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-competitive award to the established vendor. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,513.48 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product for cholesterol management. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.13 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a specialty pharmaceutical product. This non-competitive delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $17,942.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease treatment. The contract, issued on December 9, 2025, with completion scheduled for December 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized no set-aside designation, indicating the...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0PTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,077.75 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for treating high cholesterol. The contract, awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order reflects the company's role as a critical pharmaceutical distributor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 12/11/25 |